{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:51:37Z","timestamp":1771300297665,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010032","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.psychres.2021.113723","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T11:15:13Z","timestamp":1610622913000},"page":"113723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Plasma levels of interleukin-6 and antidepressant response to Paroxetine in Chinese depressive patients"],"prefix":"10.1016","volume":"297","author":[{"given":"Zaiquan","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liantian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2021.113723_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","article-title":"Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: comparison of multiple ketamine infusions and electroconvulsive therapy","volume":"100","author":"Allen","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.psychres.2021.113723_bib0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/cap.2015.0147","article-title":"The Relationship between plasma cytokine Levels and Response to selective serotonin reuptake Inhibitor Treatment in Children and Adolescents with Depression and\/or Anxiety Disorders","volume":"26","author":"Amitai","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2021.113723_bib0003","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.psychres.2021.113723_bib0004","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry."},{"issue":"2","key":"10.1016\/j.psychres.2021.113723_bib0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"10","key":"10.1016\/j.psychres.2021.113723_bib0006","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mp.2015.168","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","volume":"21","author":"Felger","year":"2016","journal-title":"Mol. Psychiatry."},{"issue":"4","key":"10.1016\/j.psychres.2021.113723_bib0007","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/13543784.2014.998334","article-title":"Novel investigational drugs targeting IL-6 signaling for the treatment of depression","volume":"24","author":"Fonseka","year":"2015","journal-title":"Expert Opin. Investig. Drugs."},{"issue":"2","key":"10.1016\/j.psychres.2021.113723_bib0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J. Clin. Psychiatry."},{"issue":"12","key":"10.1016\/j.psychres.2021.113723_bib0009","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2021.113723_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2021.113723_bib0011","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbi.2012.06.001","article-title":"A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity","volume":"26","author":"Hiles","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psychres.2021.113723_bib0012","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2021.113723_bib0013","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","article-title":"The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature","volume":"242","author":"Johnston","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2021.113723_bib0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000484665","article-title":"Both serum brain-derived neurotrophic factor and interleukin-6 levels are not associated with therapeutic response to lamotrigine augmentation therapy in treatment-resistant depressive disorder","volume":"75","author":"Kagawa","year":"2017","journal-title":"Neuropsychobiology"},{"issue":"23","key":"10.1016\/j.psychres.2021.113723_bib0015","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1001\/jama.289.23.3152","article-title":"Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond","volume":"289","author":"Keller","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.psychres.2021.113723_bib0016","doi-asserted-by":"crossref","first-page":"e1065","DOI":"10.1038\/tp.2017.31","article-title":"Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome","volume":"7","author":"Kiraly","year":"2017","journal-title":"Transl. Psychiatry."},{"key":"10.1016\/j.psychres.2021.113723_bib0017","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1038\/srep09009","article-title":"Stat3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior","volume":"5","author":"Kong","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2021.113723_bib0018","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2019.01.027","article-title":"Jak2\/stat3 signaling mediates IL-6-inhibited neurogenesis of neural stem cells through DNA demethylation\/methylation","volume":"79","author":"Kong","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.psychres.2021.113723_bib0019","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2021.113723_bib0020","first-page":"3","article-title":"The increasing burden of depression","volume":"7","author":"L\u00e9pine","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"12","key":"10.1016\/j.psychres.2021.113723_bib0021","doi-asserted-by":"crossref","first-page":"940","DOI":"10.30773\/pi.2019.0117","article-title":"C-reactive protein gene variants in depressive symptoms & antidepressants efficacy","volume":"16","author":"Li","year":"2019","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.psychres.2021.113723_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/7854_2016_2","article-title":"Evidence for inflammation-associated depression","volume":"31","author":"Liu","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2021.113723_bib0023","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chc.2012.01.001","article-title":"Child and adolescent depression intervention overview: what works, for whom and how well?","volume":"21","author":"Maalouf","year":"2012","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"issue":"11","key":"10.1016\/j.psychres.2021.113723_bib0024","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.psychres.2021.113723_bib0025","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry."},{"issue":"10","key":"10.1016\/j.psychres.2021.113723_bib0026","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.5664\/jcsm.3070","article-title":"Serum inflammatory markers in obstructive sleep apnea: a meta-analysis","volume":"9","author":"Nadeem","year":"2013","journal-title":"J. Clin. Sleep Med."},{"issue":"1","key":"10.1016\/j.psychres.2021.113723_bib0027","doi-asserted-by":"crossref","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF-\u03b1 and CRP in Elderly Patients with Depression or Alzheimer's disease: systematic Review and Meta-Analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.psychres.2021.113723_bib0028","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2021.113723_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Mol. Psychiatry."},{"issue":"10","key":"10.1016\/j.psychres.2021.113723_bib0030","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2021.113723_bib0031","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/phar.1576","article-title":"Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression","volume":"35","author":"Thomas","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.psychres.2021.113723_bib0032","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.3390\/ijms21062194","article-title":"Role of interleukin-6 in depressive disorder","volume":"21","author":"Ting","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.psychres.2021.113723_bib0033","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jad.2009.02.013","article-title":"Body weight as a predictor of antidepressant efficacy in the","volume":"118","author":"Uher","year":"2009","journal-title":"Gendep Project J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.psychres.2021.113723_bib0034","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of the outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry."},{"issue":"5","key":"10.1016\/j.psychres.2021.113723_bib0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","article-title":"Neopterin production, tryptophan degradation, and mental depression: What is the link?","volume":"16","author":"Widner","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psychres.2021.113723_bib0036","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jad.2019.07.045","article-title":"Inflammatory markers and treatment outcomes in treatment-resistant depression: a systematic review","volume":"257","author":"Yang","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2021.113723_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2014.06.021","article-title":"Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect of ketamine in treatment-resistant patients with major depression","volume":"77","author":"Yang","year":"2015","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.psychres.2021.113723_bib0038","doi-asserted-by":"crossref","unstructured":"Yoshimura, R., Hori, H., Ikenouchi-Sugita, A., Umene-Nakano, W., Katsuki, A., Atake, K., Nakamura, J., 2013. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder (MDD) Psychopharmacol. 28(5), 466\u2013470. DOI: 10.1002\/hup.2333.","DOI":"10.1002\/hup.2333"},{"issue":"4","key":"10.1016\/j.psychres.2021.113723_bib0039","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) levels are associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178121000202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178121000202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:48:05Z","timestamp":1759038485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178121000202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"alternative-id":["S0165178121000202"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2021.113723","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of interleukin-6 and antidepressant response to Paroxetine in Chinese depressive patients","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2021.113723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113723"}}